The 58 kDa mouse selenoprotein is a BCNU-sensitive thioredoxin reductase  by Gromer, Stephan et al.
FEBS Letters 412 (1997) 318-320 FEBS 18964 
The 58 kDa mouse selenoprotein is a BCNU-sensitive thioredoxin 
reductase 
Stephan Gromer, R. Heiner Schirmer, Katja Becker* 
Biochemie-Zentrum der Universitdt Heidelberg, 5. OG, Im Neuenheimer Feld 328, D-69120 Heidelberg, Germany 
Received 9 May 1997; revised version received 18 June 1997 
Abstract The flavoprotein thioredoxin reductase [EC 1.6.4.5] 
(NADPH+H++thioredoxin-S2 -> NADP++thioredoxin-(SH)2) 
was isolated from mouse Ehrlich ascites tumour (EAT) cells. 
Like the counterpart from human placenta but unlike the known 
thioredoxin reductases from non-vertebrate organisms, the 
mouse enzyme was found to contain 1 equivalent of selenium 
per subunit of 58 kDa. The KM values were 4.5 JJM for NADPH, 
480 uM for DTNB and 36 uM for Escherichia coli thioredoxin, 
the turnover number with DTNB being = 4 0 s _ 1 . As mouse is a 
standard animal model in cancer and malaria research, 
thioredoxin reductase and glutathione reductase |EC 1.6.4.2] 
from EAT cells were compared with each other. While both 
enzymes in their 2-electron reduced form are targets of the 
cytostatic drug carmustine (BCNU), no immunologic cross-
reactivity between the two mouse disulfide reductases was 
observed. 
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1. Introduction 
Only very few mammalian selenoenzymes, such as gluta-
thione peroxidase and thyroid hormone deiodinase, have so 
far been identified [1,2]. H u m a n thioredoxin reductases, di-
meric flavoenzymes with subunit MT values of 55 kDa, were 
reported to contain one selenocysteine per subunit [3-5]. This 
suggested to us that the 58 k D a band described in mouse 
selenoprotein maps [6,7] might represent thioredoxin reduc-
tase. Thioredoxin reductases exhibit a rather broad substrate 
specificity [8-13]. Inter alia they are involved in deoxyribonu-
cleotide synthesis [9], in cellular redox control [14] and in the 
detoxification of endogenous cytotoxins like TVX-lysin [10]. It 
is furthermore noteworthy that thioredoxin reductase activity 
in all tumour cell lines studied so far is by an order of mag-
nitude higher than in normal cells ([4] and references therein). 
High molecular weight thioredoxin reductases are closely 
related to glutathione reductase [5,8,9,15,16]. Mouse gluta-
thione reductase has been studied in detail as a marker anti-
gen and as a target of cytostatic and antiparasitic agents such 
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as carmustine [17,18]. A number of effects ascribed to gluta-
thione reductase inhibition in vivo may in fact concern the 
newly discovered thioredoxin reductase. In the present study 
we therefore directly compared TrxR with GR. 
2. Materials and methods 
2.1. Materials and assay systems 
EAT cells HD 34 [19] were a gift of Prof. C. Granzow, Heidelberg; 
E. coli thioredoxin was kindly provided by Prof. C.H. Williams Jr., 
Ann Arbor, MI, and carmustine (BCNU) by Prof. G. Eisenbrand, 
Kaiserslautern. Rabbit anti-(human placenta thioredoxin reductase)-
serum (Eurogentec) and rabbit anti-(human glutathione reductase)-
serum were used as described in [20]. Porcine horseradish peroxi-
dase-coupled anti-(rabbit IgG)serum was from DAKO, Hamburg. 
All chemicals used were of the highest available purity. Protein was 
determined using the BioRad protein assay [21], with bovine serum 
albumin (Pierce) serving as a standard. Glutathione reductase was 
assayed as described in [25]. For thioredoxin reductase activity, the 
two assays described in [22] were used at 25°C. The DTNB reduction 
assay proved to be sufficiently specific for monitoring the purification 
process. Using this assay one enzyme unit is defined as the NADPH-
dependent production of 2 u.mol 2-nitro-5-thiobenzoate (£412™ 13.6 
m M - 1 cm - 1) per min. Bovine serum albumin in the assay buffer 
resulted in up to 25% increase in activity but was omitted in order 
to obtain standardized results. The experiments with the cytostatic 
agent carmustine were conducted as described in [5]. 
2.2. Isolation of thioredoxin reductase from EA T cells 
Unless explicitly otherwise stated, all steps of enzyme purification 
were carried out at 0^-°C. 
Eighteen milliliters of a frozen EAT cell pellet was thawed in the 
presence of 11 ml of extraction buffer at 38^10°C (10 uM FAD, 
100 uM PMSF in TE buffer). Another 20 ul aliquot of 100 mM 
PMSF was added, and the suspension was stirred magnetically for 
10 min at 4°C. The homogenate was adjusted to pH 8.3 with 5 M 
NH4OH, and 6 ml of a —20°C cold mixture of chloroform/1-butanol 
(2:5, v:v) was added rapidly under vigorous stirring. Most hemepro-
teins and pyridine nucleotide-dependent oxidoreductases denature 
under these conditions [23] but GR and TrxR are recovered in high 
yields. The brownish mass was stirred for another 10 min, left for 1 h 
and then centrifuged for 30 min at 29 000 Xg. The supernatant was set 
aside while the precipitate was resuspended in 7 ml of extraction 
buffer and centrifuged as above. The supernatants were combined, 
filtered through glass wool and adjusted to pH 8.3. This fraction 
contained 13 U TrxR. 
Per 1 ml of the chloroform-butanol extract, 1 ml of cold acetone 
was slowly added under stirring. The resulting suspension was left for 
1 h and then centrifuged (10 min, 26000Xg). The pellet was taken up 
in a small volume of TE buffer, dialysed exhaustively against 2-fold 
diluted TE buffer and centrifuged (20 min, 29000Xg). The superna-
tant was set aside, the precipitate was resuspended in 2 ml of TE 
buffer and again centrifuged. 
The combined supernatants were applied to a 1 X 7 cm DEAE-52 
cellulose column (Whatman), equilibrated with TE buffer and oper-
ated at room temperature. After washing the column with 2 vol. of 
TE buffer and 1 .vol of 50 mM NaCl in TE buffer, thioredoxin 
reductase activity was eluted with 90 mM NaCl in TE buffer. The 
pool was concentrated, washed with TE buffer in a Centricon 30 
(Amicon) and applied to a 0.6X2.6 cm column of TE-equilibrated 
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Fig. 1. SDS-PAGE and silver staining of 150 ng mouse thioredoxin reductase. The apparent subunit molecular mass of 58 kDa is probably by 
5% too high (see text). Immunoblots demonstrating specific reactivity of human and mouse TrxR and GR with the cognate antisera. Lanes 1 
and 5: 100 ng human glutathione reductase; lanes 2 and 6: 100 ng mouse glutathione reductase; lanes 3 and 7: 100 ng human thioredoxin re-
ductase; lane 4 and 8: 100 ng mouse thioredoxin reductase. The proteins in lanes 1^1 where exposed to rabbit anti-(human thioredoxin reduc-
tase)serum and in lanes 5-8 to rabbit anti-(human glutathione reductase)serum. 
2',5'-ADP-Sepharose 4B (Pharmacia) which was subsequently rinsed 
with 2 vol. of the same buffer. 
To remove non-specifically bound protein at high ionic strength the 
column was consecutively washed with 1 vol. 100 mM KC1 in TE 
buffer, 0.7 vol. 200 mM KC1 in TE buffer and 1 vol. 100 mM KC1 
in TE buffer. In order to prepare the column for specific elution steps 
the ionic strength was then decreased using 2 vol. 2-fold diluted TE 
buffer. Even though most pyridine nucleotide-dependent enzymes had 
been removed in the first purification step(s) (see above) some specif-
ically binding protein remained. NAD(H) binding proteins were re-
moved with 2 vol. 1.2 mM NADH in TE buffer and 2 vol. of TE 
buffer. To remove contaminating NADP(H) binding proteins the col-
umn was washed with 2 vol. 100 uM NADP+ in TE buffer and finally 
with 1 vol. 500 (iM NADP+ in TE buffer. TrxR activity was eluted 
with 1.5 mM NADP+. (The GR which was still on the column can be 
eluted and purified as a electrophoretically homogeneous protein ac-
cording to [17].) The TrxR pool — which was now free of GR activity 
— was concentrated and washed with TE buffer in a Centricon 30. To 
remove residual contaminating proteins of 20-30 kDa (as judged by 
SDS-PAGE) the pool was reapplied to the regenerated 2',5'-ADP-
Sepharose column. The column was washed with 2 vol. 50 uM 
NADPH in TE buffer and 1 vol. 150 uM NADPH in TE buffer before 
TrxR activity was eluted with 500 |iM NADPH in TE buffer. The 
pool was concentrated and washed in a Centricon 30. Purity was 
checked by 10% SDS-PAGE (BioRad) and silver staining (Quick-sil-
ver, Amersham). 
Table 1 
Comparison of human placenta thioredoxin reductase and mouse EAT thioredoxin reductase 
Protein Human TrxR Mouse TrxR 
Source 
Subunit Mr 
Selenium content per mol subunit 
Specific activity (DTNB reduction assay) 
KM for NADPH (DTNB reduction assay) 
KM for DTNB 
KM for E. coli thioredoxin 
Reaction with anti-(human thioredoxin reductase)serum 
Reaction with anti-(human glutathione reductase)serum 
Effect of 1 mM carmustine 
in the absence of NADPH 
in the presence of 100 uM NADPH 
Placenta (0.2 U/g) 
55 kDa 
0.93 mol 
35 U/mg 
6.5 uM 
400 |xM 
25 uM 
yes 
none 
no inhibition 
inactivating modification 
EAT cells (1 
55 kDa 
0.94 mol 
37 U/mg 
4.5 |xM 
480 |xM 
36 uM 
yes 
none 
-2 U/g) 
The data for human TrxR apply for the enzyme isolated from placenta [5,22,33], Isoenzymes have been reported for human lung adenocarcinoma 
cells [3] and human T-cells [4]. The kinetic data shown for the human and mouse EAT enzyme are comparable with rat liver TrxR [8]. 
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The selenium contents of a 250 ul sample containing 550 nM TrxR 
subunits and of a 250 ul protein-free TE buffer as a control were 
determined by atomic absorption spectroscopy at Runnebaum and 
Fuchs Laboratories, Heidelberg. 
3. Results and discussion 
From 18 ml of packed Ehrlich ascites tumour cells 20 ng 
thioredoxin reductase with a specific activity of 37 U/mg was 
isolated. The enzyme was more than 98% pure by SDS-PAGE 
analysis. The purification procedure allows the simultaneous 
preparation of glutathione reductase. The specific activity of 
the purified GR (189 U/mg) compares well with the value 
reported previously [17]. As shown in Table 1 and Fig. 1, 
mouse thioredoxin reductase closely resembles its human 
counterpart in selenium content as well as in its enzymatic 
and immunologic properties. The subunit sizes of 58 kDa 
for mouse TrxR and 55 kDa for mouse GR, as judged from 
the SDS-PAGE analysis, are similar for the respective human 
enzymes (Fig. 1). Disulfide reductases tend to exhibit a 5% 
higher Mt by SDS-PAGE analysis than by amino-acid se-
quence analysis [4,5,15,17]. Therefore we used an MT value 
of 55 kDa per FAD-containing TrxR subunit for stoichiomet-
ric calculations. With respect to the selenium content, thiore-
doxin reductase represents one and possibly the only function 
associated with the 55-60 kDa band described for mouse se-
lenoprotein maps [6,7]. 
NADPH-reduced glutathione reductase can be irreversibly 
inactivated by carmustine (BCNU) whereas the enzyme in its 
oxidized state is not affected. The nature of this modification, 
a carbamoylation of the distal catalytic site-cysteine, has been 
studied in atomic detail for the human enzyme [24,25]. As 
shown in Table 1, reduced mouse thioredoxin reductase 
was, as its human equivalent [5,26], also irreversibly modified 
by BCNU at therapeutic concentrations. Consequently the 
possibility that thioredoxin reductase is the major target of 
nitrosourea drugs must be considered. 
Despite the detailed pharmacological similarity of the two 
disulfide reductases, thioredoxin reductase does not react with 
anti-(human glutathione reductase)serum and vice versa (Fig. 
1). This result indicates that differential immunolocalisation of 
the two disulfide reductases in the mouse brain [18] is possible 
when studying the effects of cytostatic or antimalarial drugs. 
Like humans, mice are susceptible to cerebral malaria [27]. 
Thioredoxin reductase of Plasmodium falciparum, the causa-
tive agent of human tropical malaria, is not a selenoenzyme 
[16,28]. This difference between mammalian host and parasite 
enzyme might be exploited for the design of selective antipar-
asitic drugs [29]. Similar considerations apply to other patho-
gens like fungi and bacteria, whose thioredoxin reductases 
differ greatly from their mammalian counterparts (see 
[5,9,30,31] for references). 
Our results support the notion of Holmgren and coworkers 
[32], that the selenium content is not a peculiarity of the 
human enzyme but a feature of various mammalian thiore-
doxin reductases. 
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